The Vanguard Group Announces Disclosure of Interests in Spire Healthcare

The Vanguard Group, Inc. has filed a Form 8.3 disclosure concerning its position in Spire Healthcare Group plc. As of 28 January 2026, Vanguard holds 14,394,801 shares, representing 3.57% of Spire's ordinary shares. The disclosure adheres to Rule 8.3 of the Takeover Code, indicating Vanguard's interest in securities exceeding 1%.

The report outlines a recent transaction where Vanguard sold 52,113 ordinary shares at 2.09 GBP per unit. No other stock-settled or cash-settled derivatives are currently reported, nor are there any new agreements or options relating to these positions.

Vanguard confirmed no indemnity or other dealing arrangements exist in relation to these securities. The form submission was processed on 29 January 2026, and further information can be referenced by contacting Shawn Acker at the provided number.